Fred Hutchinson Cancer Research Center raised over $13 million in donations at its recent Hutch Holiday Gala, the center's largest annual fundraiser held in Seattle each year. Money from the event will be used to recruit world-class researchers in pediatric oncology and to expand research infrastructure geared specifically toward pediatric cancer research.Read More
Science Market Update
DefeatHIV, an initiative based out of the Fred Hutchinson Cancer Research Center in Seattle, WA, has been researching potential cures for HIV over the past 5 years. Their research has focused on the use of blood cells genetically modified to be resistant to the HIV virus. It was recently announced that the National Institutes of Health (NIH) awarded the DefeatHIV team a new grant of $23.5 million that will continue to support their research on this potential cure for an additional 5 years.Read More
Small-cell lung cancer (SCLC) makes up about 10 - 15% of all lung cancer diagnoses, and is caused by smoking and inhaling second-hand smoke. This is an aggressive type of cancer that spreads quickly, and recurs extremely frequently after patients undergo chemotherapy treatments. Treatments for SCLC have not changed much in the past 30 years, but a team of researchers led by the Fred Hutchinson Cancer Research Center in Seattle has been investigating potential new therapy methods for the cancer and recently uncovered a gene that has the potential to be used in biology-based treatments for SCLC. (Image courtesy of Lindsay Fox via Wikimedia Commons and EcigaretteReviewed)Read More
Millions of people suffer from allergies nationwide, (up to 30% of Americans, according to the Center for Disease Control), but for most, a healthy immune system and a course of antihistamines is all that is needed for a little relief.
For others, however, diseases that complicate and degrade the immune system make every microbe and bacteria a potentially fatal nightmare. In recent years, people suffering from immune deficiencies have found some home in stem-cell transplants and other therapies, but their hope is tempered by inherent toxicities and associated side effects.Read More
Tags: Fred Hutchinson Cancer Research Center, Washington, immunotherapy, Stem cell research, WA, NIH funded Research Projects, Immune System, grants, 2015, BioResearch Product Faire Event, Research Funding, Stem Cell, Seattle, Northwest Region, Hutch, Fred Hutch
Brain surgery is an extremely delicate matter, and complicated even further when performed on children with brain cancer. These cancer cells are difficult to discern from healthy cells during brain surgery and afterward may or may not still reside in the brain where they can continue to spread and cause damage.Read More
Pancreatic cancer is one of the most rapidly spreading cancers known to man, which translates to seriously staggering death rates. According to the American Cancer Society, for all stages of pancreatic cancer combined, the one-year relative survival rate is 20%, and the five-year rate is 6%, in part because more than 80% of patient tumors have spread beyond the pancreas by the time of diagnosis. In most cases, the cancer has already spread to the point where surgical removal is impossible. (Image: Test Molecule; Los Angeles Mission College)Read More
Researchers at Fred Hutchinson Cancer Research Center have discovered that high blood concentrations of omega-3 fatty acids increase risk of prostate cancers. The latest investigations indicate that high concentrations of EPA, DPA, and DHA, which are metabolically related to fatty acids and derived from fatty fish and fish-oil supplements, are associated with a 71% increased risk of high-grade prostate cancer and an overall 43% increase in risk for all prostate cancers.
Fred Hutchinson Cancer Research Center recently received an $11 million life science research grant from the National Institutes of Health to fund the HIV Vaccine Trials Network. The organization within the NIH providing this latest round of life science funding is the National Institute of Allergy and Infectious Diseases. Project leader Dr. Margaret Juliana McElrath is a professor of medicine at the University of Washington. Her research lab studies are focused on identifying and characterizing cellular immune responses that may help protect patients against HIV infection or disease.
Researchers at the Fred Hutchinson Cancer Research Center have recently demonstrated that lacking one copy of a gene called CTCF causes mice to develop cancer. CTCF is a DNA binding protein that exerts a major influence on the architecture of the human genome. It has been well studied but never linked to cancer.
The Fred Hutchinson Cancer Research Center received a donation of $20 million from Mike Bezos, a family member of Amazon CEO Jeff Bezos this April to support development of novel cancer immunotherapies. This donation is the largest single contribution in the Fred Hutchinson Cancer Center’s history.